Natural products: the next frontier in drug discovery

In this new podcast, Bruker’s Kate Stumpo talks with Enveda’s Pelle Simpson on the opportunities of natural products in the field of multiomics.

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma – Biotech Investments

Issuer: CureVac / Key word(s): Study 15.08.2024 / 13:03 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Advances Cancer Vaccine

August 16, 2024

Nucleus RadioPharma Secures Investment from AstraZeneca

What You Should Know: – Nucleus RadioPharma, the world’s first comprehensive radiopharmaceutical organization, today announced the closing of an extended Series A funding round with

June 6, 2024

BARDA orders more smallpox and mpox vaccines from Bavarian Nordic

BARDA is continuing its drive to secure more smallpox vaccines, inking another order with manufacturer Bavarian Nordic. The Danish manufacturer received an order from BARDA

August 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.